Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment

by Pantano, Francesco, Guida, Francesco Maria, Vivaldi, Caterina, Vincenzi, Bruno, Grande, Enrique, Garrote, Mercedes Rodriguez, Caraglia, Michele, Silvestris, Nicola, Vasile, Enrico, Masi, Gianluca, Falcone, Alfredo, Tonini, Giuseppe, Santini, Daniele
Published 2013

Second-line chemotherapy in advanced biliary cancer progressed to first-line platinum-gemcitabine combination: a multicenter survey and pooled analysis with published data

by Fornaro, Lorenzo, Vivaldi, Caterina, Cereda, Stefano, Leone, Francesco, Aprile, Giuseppe, Lonardi, Sara, Silvestris, Nicola, Santini, Daniele, Milella, Michele, Caparello, Chiara, Musettini, Gianna, Pasquini, Giulia, Falcone, Alfredo, Brandi, Giovanni, Sperduti, Isabella, Vasile, Enrico
Published in J Exp Clin Cancer Res (2015)

FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules

by Foschini, Francesca, Napolitano, Fabiana, Servetto, Alberto, Marciano, Roberta, Mozzillo, Eleonora, Carratù, Anna Chiara, Santaniello, Antonio, De Placido, Pietro, Cascetta, Priscilla, Butturini, Giovanni, Frigerio, Isabella, Regi, Paolo, Silvestris, Nicola, Delcuratolo, Sabina, Vasile, Enrico, Vivaldi, Caterina, Bianco, Cataldo, De Placido, Sabino, Formisano, Luigi, Bianco, Roberto
Published in Ther Adv Med Oncol (2020)

Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience

by Rovesti, Giulia, Orsi, Giulia, Kalliopi, Andrikou, Vivaldi, Caterina, Marisi, Giorgia, Faloppi, Luca, Foschi, Francesco Giuseppe, Silvestris, Nicola, Pecora, Irene, Aprile, Giuseppe, Molinaro, Eleonora, Riggi, Laura, Ulivi, Paola, Canale, Matteo, Cucchetti, Alessandro, Tamburini, Emiliano, Ercolani, Giorgio, Fornaro, Lorenzo, Andreone, Pietro, Zavattari, Patrizia, Scartozzi, Mario, Cascinu, Stefano, Casadei-Gardini, Andrea
Published in Gastrointest Tumors (2019)

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib

by Caputo, Francesco, Dadduzio, Vincenzo, Tovoli, Francesco, Bertolini, Giulia, Cabibbo, Giuseppe, Cerma, Krisida, Vivaldi, Caterina, Faloppi, Luca, Rizzato, Mario Domenico, Piscaglia, Fabio, Celsa, Ciro, Fornaro, Lorenzo, Marisi, Giorgia, Conti, Fabio, Silvestris, Nicola, Silletta, Marianna, Lonardi, Sara, Granito, Alessandro, Stornello, Caterina, Massa, Valentina, Astara, Giorgio, Delcuratolo, Sabina, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea
Published in PLoS One (2020)

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

by Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe
Published in Oncologist (2017)

Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy

by Fanotto, Valentina, Uccello, Mario, Pecora, Irene, Rimassa, Lorenza, Leone, Francesco, Rosati, Gerardo, Santini, Daniele, Giampieri, Riccardo, Di Donato, Samantha, Tomasello, Gianluca, Silvestris, Nicola, Pietrantonio, Filippo, Battaglin, Francesca, Avallone, Antonio, Scartozzi, Mario, Lutrino, Eufemia Stefania, Melisi, Davide, Antonuzzo, Lorenzo, Pellegrino, Antonio, Ferrari, Laura, Bordonaro, Roberto, Vivaldi, Caterina, Gerratana, Lorenzo, Bozzarelli, Silvia, Filippi, Roberto, Bilancia, Domenico, Russano, Marco, Aprile, Giuseppe
Published in Oncologist (2018)